Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cimetidine 100 mg proposed for switch in Canada, could be approved by April.

This article was originally published in The Tan Sheet

Executive Summary

CANADIAN CIMETIDINE 100 MG Rx-TO-OTC SWITCH PROPOSED by Health Canada in the Nov. 16 issue of Canada Gazette, the country's Federal Register equivalent. "This deregulatory initiative will permit cimetidine tablets to be available without a prescription," the notice states. The proposal is open to public comment for 30 days following publication. There is no marketing exclusivity granted for switch applications in Canada.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086366

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel